Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Special MTA: None
ATGGGGGTCGTGGAAACACCCCGCAGCGCGTTGAAAGTCACCGCACAGCCGAACGACGTA
CTACTAGGAAATTACGTAGTTCTGTCCCCGCAGACCGTGCTCAAGAGCTCCAAGCTGGCC
CCCGTGCACCCTCTAGCAGAGCAGGTGAAAATAATAACGCATAACGGGAGGGCTGGCCGT
TACCAGGTCGACGGATATGACGGCAGGGTCCTACTACCATGTGGATCGGCCATTCCGGTC
CCTGAGTTCCAAGCTTTGAGCGAGAGCGCCACTATGGTGTACAACGAAAGGGAGTTCGTC
AACAGGAAACTATACCATATTGCCGTTCACGGACCGTCGTTGAACACCGACGAGGAGAAC
TACGAGAAAGTCAGAGCTGAAAGAACTGACGCCGAGTACGTGTTCGACGTAGACAAAAAA
TGCTGCATCAAGAGAGAGGAAGCGTCGGGTTTGGTGTTGGTGGGAGAGCTAACCAACCCC
CCGTTCCATGAATTCGCTTACGAAGGGCTGAAGATCAGGCCGTCGGCACCATATAAGACT
ACAGTAGTAGGAGTCTTTGGGGTTCCGGGATCAGGCAAGTCTGCTATTATCAAGAGCCTC
GTGACCAAACACGACCTGGTCACCAGCGGCAAGAAGGAGAACTGCCAGGAAATAGTCAAC
GACGTGAAGAAGCACCGCGGACTGGACATCCAGGCAAAAACAGTGGACTCCATCCTGCTA
AACGGGTGTCGTCGCGCCGTGGACATCCTATATGTGGACGAGGCTTTTGCTTGCCATTCC
GGTACTCTGCTGGCCCTAATTGCTCTTGTTAAACCTCGGAGCAAAGTGGTGTTATGCGGA
GACCCCAAGCAATGCGGATTCTTCAATATGATGCAGCTTAAGGTGAACTTCAACCATAAC
ATCTGCACTGAAGTATGTCATAAAAGTATATCCAGACGTTGCACGCGTCCAGTCACGGCC
ATCGTGTCTACGTTGCACTACGGAGGCAAGATGCGCACGACCAACCCGTGTAACAAACCC
ATAATTATAGACACCACAGGACAGACCAAGCCCAAGCCAGGAGACATTGTGTTAACATGC
TTCCGAGGCTGGGTAAAGCAGCTGCAATTGGACTATCGTGGACACGAAGTCATGACAGCA
GCAGCATCTCAGGGCCTCACCCGCAAAGGGGTATACGCCGTAAGGCAGAAGGTGAATGAA
AATCCCTTGTATGCCCCTGCGTCGGAGCACGTGAATGTACTGCTGACGCGCACTGAGGAT
AGGCTGGTGTGGAAAACGCTGGCCGGCGATCCCTGGATTAAGGTCCTATCAAACATTCCA
CAGGGTAACTTTACGGCCACATTGGAAGAATGGCAAGAAGAACACGACAAAATAATGAAG
GTGATTGAAGGACCGGCTGCGCCTGTGGACGCGTTCCAGAACAAAGCGAACGTGTGTTGG
GCGAAAAGCCTGGTGCCTGTCCTGGACACTGCCGGAATCAGATTGACAGCAGAGGAGTGG
AGTACCATAATTACAGCATTTAAGGAGGACAGAGCTTACTCTCCAGAGGTGGCCTTGAAT
GAAATTTGCACCAAGTACTATGGAGTCGACCTGGACAGTGGCCTGTTTTCTGCCCCGAAG
GTGTCCCTGTATTACGAGAACAACCACTGGGATAACAGACCAGGTGGAAGGATGTATGGA
TTCAATGCCGCAACAGCTGCCAGGCTGGAAGCTAGACATACCTTCCTGAAGGGGCAGTGG
CATACGGGCAAGCAGGCAGTAATCGCAGAAAGAAAAATCCAACCGCTTTCTGTGCTGGAC
AATGTGATTCCCATCAACCGCAGGCTACCGCACGCCCTGGTGGCTGAGTACAAGACGGTT
AAAGGCAGTAGGGTTGAGTGGCTGGTCAATAAAGTAAGAGGGTACCACGTCCTGCTGGTG
AGCGAGTACAACCTGGCTTTGCCTCGACGCAGGGTCACTTGGCTGTCACCGCTGAATGTC
ACAGGTGCCGATAGGTGCTACGACCTAAGTTTAGGACTGCCGGCTGACGCCGGCAGATAC
GACTTGGTCTTTGTGAACATTCACACGGAATTCAGAATCCACCACTACCAGCAGTGTGTC
GACCACGCTATGAAGCTGCAGATGCTGGGGGGAGATGCACTACGACTGCTAAAACCCGGC
GGCAACCTCTTGATGAGAGCTTACGGATATGCCGACAAAATCAGCGAAGCCGTTGTTTCC
TCCTTAAGCAGAAAGTTCTCGTCTGCAAGAGTACTGCGCCCGGATTGTGTCACCAGCAAT
ACAGAAGTGTTCTTGCTGTTTTCCAACTTTGACAATGGAAAGAGACCCTCTACGCTACAC
CAGATGAACACCAAGCTGAGTGCCGTGTATGCCGGAGAAGCCATGCACACAGCCGGGTGC
TAA
MGVVETPRSALKVTAQPNDVLLGNYVVLSPQTVLKSSKLAPVHPLAEQVKIITHNGRAGR YQVDGYDGRVLLPCGSAIPVPEFQALSESATMVYNEREFVNRKLYHIAVHGPSLNTDEEN YEKVRAERTDAEYVFDVDKKCCIKREEASGLVLVGELTNPPFHEFAYEGLKIRPSAPYKT TVVGVFGVPGSGKSAIIKSLVTKHDLVTSGKKENCQEIVNDVKKHRGLDIQAKTVDSILL NGCRRAVDILYVDEAFACHSGTLLALIALVKPRSKVVLCGDPKQCGFFNMMQLKVNFNHN ICTEVCHKSISRRCTRPVTAIVSTLHYGGKMRTTNPCNKPIIIDTTGQTKPKPGDIVLTC FRGWVKQLQLDYRGHEVMTAAASQGLTRKGVYAVRQKVNENPLYAPASEHVNVLLTRTED RLVWKTLAGDPWIKVLSNIPQGNFTATLEEWQEEHDKIMKVIEGPAAPVDAFQNKANVCW AKSLVPVLDTAGIRLTAEEWSTIITAFKEDRAYSPEVALNEICTKYYGVDLDSGLFSAPK VSLYYENNHWDNRPGGRMYGFNAATAARLEARHTFLKGQWHTGKQAVIAERKIQPLSVLD NVIPINRRLPHALVAEYKTVKGSRVEWLVNKVRGYHVLLVSEYNLALPRRRVTWLSPLNV TGADRCYDLSLGLPADAGRYDLVFVNIHTEFRIHHYQQCVDHAMKLQMLGGDALRLLKPG GNLLMRAYGYADKISEAVVSSLSRKFSSARVLRPDCVTSNTEVFLLFSNFDNGKRPSTLH QMNTKLSAVYAGEAMHTAGC*
Coding Sequence Details
Recommended Growth Condition: